Blood sampling for pharmacokinetics

DIAGNOSTIC_TEST2 trials

Sponsors

Erasmus Medical Center, The Netherlands Cancer Institute

Conditions

Colorectal Cancer (CRC)Esophageal CancerGastric (Cardia, Body) CancerHER2 ExpressionHER2 Gene MutationLung Cancer (NSCLC)Solid Cancer

Phase 1

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

Not yet recruitingNCT07436858

The Netherlands Cancer InstituteHER2 Expression, HER2 Gene Mutation, Lung Cancer (NSCLC)

Start: 2026-09-07End: 2030-07-07Target: 20Updated: 2026-08-11

Unknown Phase

Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients

RecruitingNCT07114627

Erasmus Medical CenterColorectal Cancer (CRC), Esophageal Cancer, Gastric (Cardia, Body) Cancer +1

Start: 2025-02-18End: 2027-06-30Target: 66Updated: 2025-08-11